Page 31 - Journal of Structural Heart Disease Volume 3, Issue 4

Case Report
118
[11]. However, our case is unique because TAVR was performed in the presence of prior mitral valve pros- thesis. On the other hand, several reports have been published on TAVR in the presence of prior mitral valve prosthesis [12, 13, 14, 15, 16], although aortic stenosis in these reports was related to calci c aor- tic stenosis and not rheumatic disease as in our case. Thus, this is the rst report of TAVR for rheumatic aortic stenosis with prior mitral valve prosthesis.
In conclusion, the indications for TAVR are evolving to include a wider range of patients and di erent valvu- lar disorders. This is the rst case demonstrating the fea- sibility of TAVR for rheumatic aortic stenosis with prior
mitral valve prosthesis in the presence of high-risk fea- tures for surgical valve replacement. A registry of such patients with longer-term follow-up is necessary to es- tablish the role of TAVR in rheumatic aortic stenosis.
Con ict of Interest
The authors have no con ict of interest relevant to this publication.
Comment on this Article or Ask a Question
References
1. Leon MB, Smith CR, Mack M, Miller DC, Mo- ses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic steno- sis in patients who cannot undergo sur- gery. N Engl J Med. 2010;363:1597-1607. DOI: 10.1056/NEJMoa1008232
2. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, et al. Tran- scatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972- 1981. DOI: 10.1016/j.jacc.2014.02.556
3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcath- eter versus surgical aortic-valve replace- ment in high-risk patients. N Engl J Med. 2011;364:2187-2198. DOI: 10.1056/NE- JMoa1103510
4. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Tran- scatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798. DOI: 10.1056/NE- JMc1408396
5. Vahanian A, Al eri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of val- vular hear disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European As- sociation for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451-2496. DOI: https://doi.org/10.1093/eurheartj/ ehs109
6. Nishimura RA, Otto CM, Bonow RO, Car- abello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the man- agement of patients with valvular heart
disease: A report of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57-185. DOI: 10.1016/j.jacc.2014.02.536
7. Shah AM, Ogbara J, Herrmann HC, Fox Z, Kadakia M, Anwaruddin S, et al. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease. Cath- eter Cardiovasc Interv. 2015;86:888-894. DOI: 10.1002/ccd.25994
8. Thakkar B, Patel A, Mohamad B, Patel NJ, Bhatt P, Bhimani R, et al. Transcatheter aortic valve replacement versus surgi- cal aortic valve replacement in patients with cirrhosis. Catheter Cardiovasc Interv. 2016;87:955-962. DOI: 10.1002/ccd.26345
9. Bilge M, Saatci YA, Alemdar R, Ali S. Tran- scatheter aortic valve implantation with the CoreValve for the treatment of rheu- matic aortic stenosis. Anadolu Kardiyolo Derg. 2014;14:296-297. DOI: 10.5152/ akd.2014.5226
10. Akujuo AC, Dellis SL, Britton LW, Bennett EV, Jr. Transcatheter aortic and mitral valve implantation (TAMVI) in native rheumatic valves. J Card Surg. 2015;30:813-816. DOI: 10.1111/jocs.12612
11. Chainani V, Perez O, Hanno R, Hourani P, Rengifo-Moreno P, Martinez-Clark P, et al. Left main percutaneous coronary inter- vention and transcatheter aortic valve re- placement in a young male with rheumatic heart disease and porcelain aorta. Case Rep Cardiol. 2016; 2016:3671923. DOI: 10.1155/2016/3671923
12. Rodes-Cabau J, Dumont E, Miro S, Doyle D, De Larochelliere R, Clavel MA, et al. Apical aortic valve implantation in a pa- tient with a mechanical valve prosthesis
in mitral position. Circ Cardiovasc Interv. 2008;1:233. DOI: 10.1161/CIRCINTERVEN- TIONS.108.813592
13. Sari C, Bastug S, Ayhan H, Kasapkara HA, Durmaz T, Keles T, et al. Transfemoral aor- tic valve implantation in severe aortic stenosis patients with prior mitral valve prosthesis. Postepy Kardiol Interwen- cyjnej. 2015;11:304-311. DOI: 10.5114/ pwki.2015.55601
14. Garcia E, Albarran A, Heredia-Mantrana J, Guerrero-Pinedo F, Rodriguez J, Hernandez- -Antolin R, et al. Transcatheter aortic valve implantation in patients with a mechanical mitral valve. Rev Esp Cardiol. 2011;64:1052- 1055. DOI: 10.1016/j.recesp.2011.02.022
15. Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable su- praannular self-expanding transcatheter aortic valve system. JACC Cardiovasc In- terv. 2015;8:1359-1367. DOI: 10.1016/j. jcin.2015.05.015
16. Soon JL, Ye J, Lichtenstein SV, Wood D, Webb JG, Cheung A. Transapical tran- scatheter aortic valve implantation in the presence of a mitral prosthesis. J Am Coll Cardiol. 2011;58:715-721. DOI: 10.1016/j. jacc.2011.04.023
Journal of Structural Heart Disease, August 2017
Volume 3, Issue 4:115-118
Cite this article as: Alhaddad IA. Trans- Catheter Aortic Valve Replacement for Inoperable Severe Rheumatic Aortic Stenosis with Prior Mitral Valve Prosthesis. Structural Heart Disease. 2017;4(3):115-118. DOI: https://doi. org/10.12945/j.aorta.2015.015.16